摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氯-1,3-二溴苯 | 19230-27-4

中文名称
2-氯-1,3-二溴苯
中文别名
2-氯-1,3-二溴苯2,6-二溴-1-氯苯;1,3-二溴-2-氯苯;2,6-二溴氯苯;2,6-二溴-1-氯苯
英文名称
1,3-dibromo-2-chlorobenzene
英文别名
2-chloro-1,3-dibromobenzene;2,6-dibromo-1-chlorobenzene;2,6-dibromochlorobenzene;1,3-Dibrom-2-chlor-benzol;2-Chlor-1,3-dibrombenzol
2-氯-1,3-二溴苯化学式
CAS
19230-27-4
化学式
C6H3Br2Cl
mdl
——
分子量
270.351
InChiKey
IRPWVEBIMPXCAZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    72°C
  • 沸点:
    265°C (rough estimate)
  • 密度:
    2.3753 (rough estimate)

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2903999090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    室温且干燥环境下使用。

SDS

SDS:e0aac89b585f7bd6c0c2786fd9a1dc61
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1,3-Dibromo-2-chlorobenzene
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 1,3-Dibromo-2-chlorobenzene
CAS number: 19230-27-4

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H3Br2Cl
Molecular weight: 270.4

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

应用

2-氯-1,3-二溴苯是一种有机中间体,可以通过重氮化反应从2,6-二溴苯胺制备得到。这种化合物可用于制备电致发光材料。

制备

在65℃下,向含有亚硝酸异戊酯(585mg,5mmol)和CuCl(396mg,4mmol)的10mL乙腈溶液中缓慢加入2,6-二溴苯胺(502mg,2mmol)。反应混合物在相同温度下搅拌2小时后,逐滴加入NH4BF4溶液(4.2g,40mmol)。随后,在0-10℃下继续搅拌1小时,并冷却至室温。接着,进行减压浓缩,用乙酸乙酯(30mL)溶解,用水(20mL)洗涤有机层。将有机层经无水硫酸钠干燥后过滤并再次减压浓缩。通过柱色谱法纯化残余物,使用石油醚洗脱,最终得到固体的2-氯-1,3-二溴苯(产率49%)。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氯-1,3-二溴苯硫酸硝酸 作用下, 生成 2,4-二溴-3-氯-1,5-二硝基-苯
    参考文献:
    名称:
    Joshi; Saxena, Journal of the Indian Chemical Society, 1953, vol. 30, p. 548
    摘要:
    DOI:
  • 作为产物:
    描述:
    参考文献:
    名称:
    Koerner; Contardi, Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti, 1913, vol. <5> 22 I, p. 823
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • BORON-CONTAINING SMALL MOLECULES
    申请人:Eli Lilly and Company
    公开号:US20130131016A1
    公开(公告)日:2013-05-23
    This invention provides novel compounds, methods of using the compounds, and pharmaceutical formulations comprising the compounds.
    这项发明提供了新颖的化合物,使用这些化合物的方法,以及包含这些化合物的药物配方。
  • 1-Aryl-3,3-dialkyltriazenes: A Convenient Synthesis from Dry Arenediazonium o-Benzenedisulfonimides - A High Yield Break Down to the Starting Dry Salts and Efficient Conversions to Aryl Iodides, Bromides and Chlorides
    作者:Margherita Barbero、Iacopo Degani、Nicola Diulgheroff、Stefano Dughera、Rita Fochi
    DOI:10.1055/s-2001-18072
    日期:——
    Synthesis 2001, No. 14, 26 1
    综合 2001, No. 14, 26 1
  • [EN] SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME<br/>[FR] COMPOSÉS 1,1'-BIPHÉNYLE SUBSTITUÉS ET LEURS PROCÉDÉS D'UTILISATION
    申请人:ARBUTUS BIOPHARMA INC
    公开号:WO2021158481A1
    公开(公告)日:2021-08-12
    The present invention includes substituted 1,1'-biphenyl compounds, analogues thereof, and compositions comprising the same. In one aspect, the compounds contemplated in the invention can be used to treat, ameliorate, or prevent hepatitis B virus (HBV) and/or hepatitis D virus (HDV) infections in a patient. In another aspect, the compounds contemplated in the invention can be used to treat, ameliorate, and/or prevent cancer in a patient.
    本发明包括取代的1,1'-联苯化合物,其类似物,以及包含它们的组合物。在一个方面,本发明中考虑的化合物可用于治疗、改善或预防患者体内的乙型肝炎病毒(HBV)和/或丙型肝炎病毒(HDV)感染。在另一个方面,本发明中考虑的化合物可用于治疗、改善和/或预防患者体内的癌症。
  • Compounds and their use as BACE Inhibitors
    申请人:Csjernyik Gabor
    公开号:US20120165347A1
    公开(公告)日:2012-06-28
    The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.
    本发明涉及式(I)的化合物及其药物组合物。此外,本发明涉及治疗方法,用于治疗和/或预防与Aβ相关的病理,如唐氏综合症,β-淀粉样蛋白血管病,如但不限于脑淀粉样蛋白血管病或遗传性脑出血,与认知损害相关的疾病,如但不限于MCI(“轻度认知损害”),阿尔茨海默病,记忆丧失,与阿尔茨海默病相关的注意力缺陷症状,与疾病如阿尔茨海默病或痴呆症相关的神经退行性疾病,包括混合性血管性和退行性起源的痴呆,早老性痴呆,老年性痴呆和与帕金森病、进行性上核性麻痹或皮层基底节变性相关的痴呆。
  • 稠环类衍生物抑制剂、其制备方法和应用
    申请人:上海翰森生物医药科技有限公司
    公开号:CN111925367A
    公开(公告)日:2020-11-13
    本发明涉及稠环类衍生物抑制剂、其制备方法和应用。特别地,本发明涉及通式(I)所示的化合物、其制备方法及含有该化合物的药物组合物,及其作为抑制剂在治疗癌症、感染性疾病、自身免疫性疾病的用途,其中通式(I)中的各取代基与说明书中的定义相同。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐